Намаляване употребата на опиоиди при комбинирано лечение с Dynastat, на 2- ия и 3- ия ден е било 7, 2 mg и 2, 8 mg (съответно 37% и 28%).
The reduction in opioid use with Dynastat treatment on Days 2 and 3 was 7.2 mg and 2.8 mg (37% and 28% respectively). This reduction in opioid use was accompanied by significant reductions in patient-reported opioid symptom distress.